Hematopoietic stem cell transplantation is
a curative treatment modality for children with transfusion-dependent
Thalassemia. A transplant has been explored extensively in the last 30 years
and presently more than 4000 allogeneic transplants have been performed
worldwide. This review provides brief information on Pediatric hematopoietic
stem cell transplantation in Transfusion-dependent thalassemia with the
objective of providing outcome predictions based on modern transplant
technologies and some of the known post-transplant complications.
Author(s)
Details:-
Dr.
Shweta Pathak (Associate Professor)
Department of Pediatric Hematology, Oncology and
Bone Marrow Transplant, Netaji Subhash Chandra Bosh Medical College, Jabalpur
(MP), India.
Please see the link here:- https://doi.org/10.9734/bpi/nvmms/v9/8433E
No comments:
Post a Comment